Literature DB >> 7959685

Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.

D S Millar1, A I Wacey, J Ribando, E Melissari, B Laursen, P Woods, V V Kakkar, D N Cooper.   

Abstract

The polymerase chain reaction and direct sequencing were used to determine the nature of the mutations in the antithrombin III (AT3) gene in seven unrelated patients with familial antithrombin III (ATIII) deficiency and recurrent venous thrombosis. Three novel mutations were found, two associated with a type I deficiency state (Pro80-->Thr and His120-->Tyr) manifesting reduced synthesis of ATIII. The other novel lesion (Met251-->Ile) was associated with a dysfunctional ATIII protein (type II ATIII deficiency) and is predicted to interfere either with a heparin-induced conformational change in the ATIII molecule or with docking to thrombin. A novel polymorphism (Tyr158-->Cys) was also found to occur in several individuals of Scandinavian origin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959685     DOI: 10.1007/BF00211016

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

Review 1.  Molecular basis of inherited human antithrombin deficiency.

Authors:  M A Blajchman; R C Austin; F Fernandez-Rachubinski; W P Sheffield
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

2.  DdeI polymorphism in intron 5 of the ATIII gene.

Authors:  M E Daly; D J Perry
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

3.  Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.

Authors:  R J Olds; D Lane; R Caso; A Tripodi; P M Mannucci; S L Thein
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

4.  (ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations.

Authors:  R J Olds; D A Lane; V Chowdhury; G Sas; I Pabinger; K Auberger; S L Thein
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

5.  Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

Authors:  D A Lane; R J Olds; M Boisclair; V Chowdhury; S L Thein; D N Cooper; M Blajchman; D Perry; J Emmerich; M Aiach
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

Review 6.  A player of many parts: the spotlight falls on thrombin's structure.

Authors:  M T Stubbs; W Bode
Journal:  Thromb Res       Date:  1993-01-01       Impact factor: 3.944

7.  Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.

Authors:  R J Olds; D A Lane; V Chowdhury; V De Stefano; G Leone; S L Thein
Journal:  Biochemistry       Date:  1993-04-27       Impact factor: 3.162

8.  Recurrent deletion in the human antithrombin III gene.

Authors:  C B Grundy; F Thomas; D S Millar; M Krawczak; E Melissari; V Lindo; E Moffat; V V Kakkar; D N Cooper
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

9.  Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.

Authors:  J Y Chang
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

10.  Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.

Authors:  M Daly; D Bruce; D J Perry; J Price; P L Harper; A O'Meara; R W Carrell
Journal:  FEBS Lett       Date:  1990-10-29       Impact factor: 4.124

View more
  4 in total

1.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.

Authors:  E Verpy; M Biasotto; M Brai; G Misiano; T Meo; M Tosi
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

2.  Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.

Authors:  Gonzalo Izaguirre; Sonia Aguila; Lixin Qi; Richard Swanson; Ryan Roth; Alireza R Rezaie; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

Review 3.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Molecular evolution of plasminogen activator inhibitor-1 functional stability.

Authors:  M B Berkenpas; D A Lawrence; D Ginsburg
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.